John Rogers's HAE Position Overview
John Rogers (via Ariel Investments, LLC) currently holds 2.06 M shares of Haemonetics Corporation (HAE) worth $154.57 M, representing 1.54% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, John Rogers has initiated a new position in HAE, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
John Rogers's Haemonetics Corporation (HAE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Haemonetics Corporation (HAE) Trades by John Rogers
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +2.06 M | New Buy | 2.06 M | $75.00 |
John Rogers's Haemonetics Corporation Investment FAQs
John Rogers first purchased Haemonetics Corporation (HAE) in Q2 2026, acquiring 2,060,966 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Rogers has held Haemonetics Corporation (HAE) for 1 quarters since Q2 2026.
John Rogers's largest addition to Haemonetics Corporation (HAE) was in Q2 2026, adding 2,060,966 shares worth $154.57 M.
According to the latest 13F filing for Q2 2026, John Rogers's firm, Ariel Investments, LLC, owns 2,060,966 shares of Haemonetics Corporation (HAE), valued at approximately $154.57 M.
As of the Q2 2026 filing, Haemonetics Corporation (HAE) represents approximately 1.54% of John Rogers's publicly disclosed stock portfolio, making it one of their key holdings.
John Rogers's peak holding in Haemonetics Corporation (HAE) was 2,060,966 shares, as reported at the end of Q2 2026.